245 related articles for article (PubMed ID: 25629402)
1. Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone.
Sroga GE; Wu PC; Vashishth D
PLoS One; 2015; 10(1):e0117046. PubMed ID: 25629402
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Thomas CJ; Cleland TP; Sroga GE; Vashishth D
Bone; 2018 May; 110():128-133. PubMed ID: 29408699
[TBL] [Abstract][Full Text] [Related]
3. Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.
Karim L; Bouxsein ML
Bone; 2016 Jan; 82():21-7. PubMed ID: 26211993
[TBL] [Abstract][Full Text] [Related]
4. Fracture behavior of human cortical bone with high glycation content under dynamic loading.
Maghami E; Sadighi A; Najafi AR
J Mech Behav Biomed Mater; 2024 Jul; 155():106577. PubMed ID: 38759587
[TBL] [Abstract][Full Text] [Related]
5. Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices.
Ural A; Janeiro C; Karim L; Diab T; Vashishth D
Osteoporos Int; 2015 Mar; 26(3):865-873. PubMed ID: 25326375
[TBL] [Abstract][Full Text] [Related]
6. Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose.
Sroga GE; Siddula A; Vashishth D
PLoS One; 2015; 10(2):e0117240. PubMed ID: 25679213
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
8. Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.
Karim L; Moulton J; Van Vliet M; Velie K; Robbins A; Malekipour F; Abdeen A; Ayres D; Bouxsein ML
Bone; 2018 Sep; 114():32-39. PubMed ID: 29857063
[TBL] [Abstract][Full Text] [Related]
9. Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone.
Karim L; Tang SY; Sroga GE; Vashishth D
Osteoporos Int; 2013 Sep; 24(9):2441-7. PubMed ID: 23471564
[TBL] [Abstract][Full Text] [Related]
10. A direct role of collagen glycation in bone fracture.
Poundarik AA; Wu PC; Evis Z; Sroga GE; Ural A; Rubin M; Vashishth D
J Mech Behav Biomed Mater; 2015 Dec; 52():120-130. PubMed ID: 26530231
[TBL] [Abstract][Full Text] [Related]
11. Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach.
LLabre JE; Sroga GE; Tice MJL; Vashishth D
Bone; 2022 Mar; 156():116302. PubMed ID: 34952229
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Extracellular Bone Matrix Proteins and Its Contribution to Bone Fragility.
Sroga GE; Vashishth D
J Bone Miner Res; 2018 Dec; 33(12):2214-2229. PubMed ID: 30001467
[TBL] [Abstract][Full Text] [Related]
13. The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone.
Tang SY; Vashishth D
J Biomech; 2011 Jan; 44(2):330-6. PubMed ID: 21056419
[TBL] [Abstract][Full Text] [Related]
14. Association of Insulin-like Growth Factor-1, Bone Mass and Inflammation to Low-energy Distal Radius Fractures and Fracture Healing in Elderly Women Attending Emergency Care.
Chisalita SI; Chong LT; Wajda M; Adolfsson L; Woisetschläger M; Spångeus A
Orthop Surg; 2017 Nov; 9(4):380-385. PubMed ID: 29178313
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes and its treatments on skeletal diseases.
Yan W; Li X
Front Med; 2013 Mar; 7(1):81-90. PubMed ID: 23377889
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Mechanical, Material, and Compositional Determinants of Human Trabecular Bone Quality in Type 2 Diabetes.
Sihota P; Yadav RN; Dhaliwal R; Bose JC; Dhiman V; Neradi D; Karn S; Sharma S; Aggarwal S; Goni VG; Mehandia V; Vashishth D; Bhadada SK; Kumar N
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2271-e2289. PubMed ID: 33475711
[TBL] [Abstract][Full Text] [Related]
17. Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.
Willett TL; Voziyan P; Nyman JS
Bone; 2022 Oct; 163():116485. PubMed ID: 35798196
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
19. Diabetes, collagen, and bone quality.
Saito M; Kida Y; Kato S; Marumo K
Curr Osteoporos Rep; 2014 Jun; 12(2):181-8. PubMed ID: 24623537
[TBL] [Abstract][Full Text] [Related]
20. Advanced Glycation End Products, Diabetes, and Bone Strength.
Yamamoto M; Sugimoto T
Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
